Advertisement

Heart and Vessels

, Volume 29, Issue 4, pp 478–485 | Cite as

Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome

  • Munenori Takata
  • Eisuke Amiya
  • Masafumi WatanabeEmail author
  • Kazuko Omori
  • Yasushi Imai
  • Daishi Fujita
  • Hiroshi Nishimura
  • Masayoshi Kato
  • Tetsuro Morota
  • Kan Nawata
  • Atsuko Ozeki
  • Aya Watanabe
  • Shuichi Kawarasaki
  • Yumiko Hosoya
  • Tomoko Nakao
  • Koji Maemura
  • Ryozo Nagai
  • Yasunobu Hirata
  • Issei Komuro
Original Article

Abstract

Marfan syndrome is an inherited disorder characterized by genetic abnormality of microfibrillar connective tissue proteins. Endothelial dysfunction is thought to cause aortic dilation in subjects with a bicuspid aortic valve; however, the role of endothelial dysfunction and endothelial damaging factors has not been elucidated in Marfan syndrome. Flow-mediated dilation, a noninvasive measurement of endothelial function, was evaluated in 39 patients with Marfan syndrome. Aortic diameter was measured at the aortic annulus, aortic root at the sinus of Valsalva, sinotubular junction and ascending aorta by echocardiography, and adjusted for body surface area (BSA). The mean value of flow-mediated dilation was 6.5 ± 2.4 %. Flow-mediated dilation had a negative correlation with the diameter of the ascending thoracic aorta (AscAd)/BSA (R = −0.39, p = 0.020) and multivariate analysis revealed that flow-mediated dilation was an independent factor predicting AscAd/BSA, whereas other segments of the aorta had no association. Furthermore, Brinkman index had a somewhat greater influence on flow-mediated dilation (R = −0.42, p = 0.008). Although subjects who smoked tended to have a larger AscAd compared with non-smokers (AscA/BSA: 17.3 ± 1.8 versus 15.2 ± 3.0 mm/m2, p = 0.013), there was no significant change in flow-mediated dilation, suggesting that smoking might affect aortic dilation via an independent pathway. Common atherogenic risks, such as impairment of flow-mediated dilation and smoking status, affected aortic dilation in subjects with Marfan syndrome.

Keywords

Marfan syndrome Flow-mediated dilation Aortic diameter Smoking status 

Notes

Acknowledgments

This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program.

Conflict of interest

The authors declare no conflict of interests.

References

  1. 1.
    Judge DP, Dietz HC (2005) Marfan’s syndrome. Lancet 366:1965–1976PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Hirata K, Triposkiadis F, Sparks E, Bowen J, Wooley CF, Boudoulas H (1991) The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol 18:57–63PubMedCrossRefGoogle Scholar
  3. 3.
    Legget ME, Unger TA, O’Sullivan CK, Zwink TR, Bennett RL, Byers PH, Otto CM (1996) Aortic root complications in Marfan’s syndrome: identification of a lower risk group. Heart 75:389–395PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Nollen GJ, Groenink M, Tijssen JG, Van Der Wall EE, Mulder BJ (2004) Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J 25:1146–1152PubMedCrossRefGoogle Scholar
  5. 5.
    Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin Sci (Lond) 120:357–375CrossRefGoogle Scholar
  6. 6.
    Lee TC, Zhao YD, Courtman DW, Stewart DJ (2000) Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345–2348PubMedCrossRefGoogle Scholar
  7. 7.
    Aicher D, Urbich C, Zeiher A, Dimmeler S, Schafers HJ (2007) Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann Thorac Surg 83:1290–1294PubMedCrossRefGoogle Scholar
  8. 8.
    De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426PubMedCrossRefGoogle Scholar
  9. 9.
    Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias JP, Laurent S (1999) Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 99:2677–2681PubMedCrossRefGoogle Scholar
  10. 10.
    Magda SL, Ciobanu AO, Florescu M, Vinereanu D (2013) Comparative reproducibility of the noninvasive ultrasound methods for the assessment of vascular function. Heart Vessels 28:143–150PubMedCrossRefGoogle Scholar
  11. 11.
    Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRefGoogle Scholar
  12. 12.
    Kilickesmez KO, Abaci O, Kocas C, Yildiz A, Kaya A, Okcun B, Kucukoglu S (2012) Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve. Heart Vessels 27:391–397PubMedCrossRefGoogle Scholar
  13. 13.
    LeMaire SA, Carter SA, Volguina IV, Laux AT, Milewicz DM, Borsato GW, Cheung CK, Bozinovski J, Markesino JM, Vaughn WK, Coselli JS (2006) Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg 81:2063–2078PubMedCrossRefGoogle Scholar
  14. 14.
    Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ, O’Fallon WM, Wiebers DO, Tajik AJ (2003) Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 42:1076–1083PubMedCrossRefGoogle Scholar
  15. 15.
    Tzemos N, Lyseggen E, Silversides C, Jamorski M, Tong JH, Harvey P, Floras J, Siu S (2010) Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol 55:660–668PubMedCrossRefGoogle Scholar
  16. 16.
    Nakamura M, Itoh S, Makita S, Ohira A, Arakawa N, Hiramori K (2000) Peripheral resistance vessel dysfunction in Marfan syndrome. Am Heart J 139:661–666PubMedCrossRefGoogle Scholar
  17. 17.
    Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S, Wilson JF, Lewis MJ, Stuart AG (1999) Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 99:909–915PubMedCrossRefGoogle Scholar
  18. 18.
    Brigdes AB, Gray JR, McLaren M, Tamei H, Belch JJF (1993) Endothelial cell and platelet function in Marfan syndrome. Endothelium 1:203–206CrossRefGoogle Scholar
  19. 19.
    Perlstein TS, Lee RT (2006) Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol 26:250–256PubMedCrossRefGoogle Scholar
  20. 20.
    Chiu JJ, Chien S (2011) Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91:327–387PubMedCrossRefGoogle Scholar
  21. 21.
    Mohamed SA, Radtke A, Saraei R, Bullerdiek J, Sorani H, Nimzyk R, Karluss A, Sievers HH, Belge G (2012) Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve. Cardiol Res Pract 2012:165957PubMedCentralPubMedGoogle Scholar
  22. 22.
    Wilmink TB, Quick CR, Day NE (1999) The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30:1099–1105PubMedCrossRefGoogle Scholar
  23. 23.
    Gao L, Zhou X, Zhang L, Wen D, Chang Q, Wu Y, Sun L, Hui R (2011) Factors influencing prognosis in patients with Marfan syndrome after aortic surgery. J Cardiothorac Vasc Anesth 25:625–631PubMedCrossRefGoogle Scholar
  24. 24.
    Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198–1203PubMedCrossRefGoogle Scholar
  25. 25.
    Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL (2011) Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 300:H388–H396PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Saijonmaa O, Nyman T, Fyhrquist F (2005) Regulation of angiotensin-converting enzyme production by nicotine in human endothelial cells. Am J Physiol Heart Circ Physiol 289:H2000–H2004PubMedCrossRefGoogle Scholar
  27. 27.
    Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, Xia L, Zhang Y, Zou MH (2012) Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med 18:902–910PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Murphy EA, Danna-Lopes D, Sarfati I, Rao SK, Cohen JR (1998) Nicotine-stimulated elastase activity release by neutrophils in patients with abdominal aortic aneurysms. Ann Vasc Surg 12:41–45PubMedCrossRefGoogle Scholar
  29. 29.
    Engelfriet PM, Drenthen W, Pieper PG, Tijssen JG, Yap SC, Boersma E, Mulder BJM (2008) Smoking and its effects on mortality in adults with congenital heart disease. Int J Cardiol 127:93–97PubMedCrossRefGoogle Scholar
  30. 30.
    Yetman AT, McCrindle BW (2010) The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol 26:137–139PubMedCrossRefGoogle Scholar
  31. 31.
    McLoughlin D, McGuinness J, Byrne J, Terzo E, Huuskonen V, McAllister H, Black A, Kearney S, Kay E, Hill ADK, Dietz HC, Redmond JM (2011) Pravastatin reduces Marfan aortic dilation. Circulation 124:S168–S173PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Munenori Takata
    • 1
  • Eisuke Amiya
    • 1
  • Masafumi Watanabe
    • 1
    Email author
  • Kazuko Omori
    • 1
    • 2
  • Yasushi Imai
    • 1
  • Daishi Fujita
    • 1
  • Hiroshi Nishimura
    • 1
  • Masayoshi Kato
    • 1
  • Tetsuro Morota
    • 3
  • Kan Nawata
    • 3
  • Atsuko Ozeki
    • 1
  • Aya Watanabe
    • 1
  • Shuichi Kawarasaki
    • 1
  • Yumiko Hosoya
    • 1
  • Tomoko Nakao
    • 1
  • Koji Maemura
    • 4
  • Ryozo Nagai
    • 1
    • 5
  • Yasunobu Hirata
    • 1
  • Issei Komuro
    • 1
  1. 1.Department of Cardiovascular Medicine, Graduate School of MedicineThe University of TokyoTokyoJapan
  2. 2.Department of Laboratory MedicineTeikyo University School of Medical TechnologyTokyoJapan
  3. 3.Department of Cardiothoracic Surgery, Graduate School of MedicineThe University of TokyoTokyoJapan
  4. 4.Department of Cardiovascular MedicineNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  5. 5.Jichi Medical SchoolTochigiJapan

Personalised recommendations